10 min read
September 29, 2021
The Dales Report – Could MDMA Be A Frontline Therapeutic For Women’s Sexual Disorders? MINDCURE CEO Kelsey Ramsden Says Yes
Shadd Dales and Kelsey Ramsden, CEO of MINDCURE, spoke about the company’s Desire Project. 40% of premenopausal women experience low desire, with 14% of premenopausal women experiencing distress. The women’s sexual desire market is underrepresented compared to men’s, and MDMA-assisted psychotherapy presents a potential solution due to feasibility and proximity to market.